Richard Gilbertson elected to EMBO membership
Senior Group Leader, Professor Richard Gilbertson, has been elected a member of the European Molecular Biology Organisation (EMBO) in recognition of his high-quality life science research.
Gilbertson is one of 67 life scientists to be elected this year, joining the community of more than 1,900 members in Europe and beyond.
“The new EMBO Members and Associate Members are exceptional scientists, who carry out leading research across a variety of fields, ranging from cell biology and cancer to vaccine development and machine learning,” says EMBO Director Fiona Watt. “I am delighted to welcome them to EMBO, and I know that they will enrich the life of the organization immensely.”
Professor Richard Gilbertson said “It is such an honour to have been elected to EMBO and be part of this incredible group of scientists and colleagues from across Europe. I very much hope to continue to promote international collaborations and interactions through my membership of this terrific organisation.”
Members provide guidance and support for EMBO activities, for example by evaluating funding applications, serving on EMBO Council and committees, or joining the editorial boards of EMBO Press journals. Through their involvement, members help to shape the direction of life sciences, foster the careers of young researchers, and strengthen the research communities in Europe and beyond.
New members are nominated and elected by the existing EMBO Membership. The annual process ensures a broad scope with the flexibility to expand into newly emerging fields in the life sciences.
EMBO will formally welcome the new members at the annual Members’ Meeting in Heidelberg between 26 and 28 October 2022.
An online directory listing all members, their affiliations, and subject areas is available here.
Related News
See all news-
Imaging technique allows rapid assessment of ovarian cancer subtypes and their response to treatment
6th December 2024
An MRI-based imaging technique developed at the Institute predicts the response of ovarian cancer tumours to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models.
Find out more -
Isabel Esain Garcia awarded PhD Thesis Prize
3rd December 2024
The Prize is awarded annually to a student who has undertaken an outstanding research project to the highest standards during the course of their PhD study at the Cancer Research UK Cambridge Institute.
Find out more -
World first trial to revolutionise treatment of brain cancer
23rd October 2024
A pioneering research study will trial multiple new treatments for people in the UK living with glioblastoma, an aggressive form of brain cancer.
Find out more